Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pallone

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Current Opinion in Pharmacology|October 18, 2011
Emerging immunological targets in inflammatory bowel diseaseGiovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Cytokine & Growth Factor Reviews|March 6, 2009
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated diseaseGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
World Journal of Gastroenterology|May 27, 2009
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathiesMassimo-C Fantini, Francesco Pallone, Giovanni Monteleone
Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Interleukin-21 (IL-21) controls inflammatory pathways in the gutDaniele Fina, Roberta Caruso, Francesco Pallone, et al.
World Journal of Gastroenterology|September 25, 2012
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?Stella Tammaro, Roberta Caruso, Francesco Pallone, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|February 3, 2007
Treatment with biologic therapies and the risk of cancer in patients with IBDLivia Biancone, Emma Calabrese, Carmelina Petruzziello, et al.
Current Opinion in Gastroenterology|June 9, 2006
New mediators of immunity and inflammation in inflammatory bowel diseaseGiovanni Monteleone, Daniele Fina, Roberta Caruso, et al.
Expert Review of Clinical Immunology|July 3, 2010
Role of IL-21 in inflammatory bowel diseaseFrancesco Pallone, Daniele Fina, Roberta Caruso, et al.
Expert Opinion on Therapeutic Targets|March 12, 2011
Targeting interleukin-21 in inflammatory diseasesMassimiliano Sarra, Eleonora Franzè, Francesco Pallone, et al.
Digestive Diseases (Basel, Switzerland)|September 15, 2015
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in ManIrene Marafini, Erika Angelucci, Francesco Pallone, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Current Opinion in Pharmacology|October 18, 2011
Emerging immunological targets in inflammatory bowel diseaseGiovanni Monteleone, Francesco Pallone, Thomas T MacDonald
Cytokine & Growth Factor Reviews|March 6, 2009
Interleukin-21 (IL-21)-mediated pathways in T cell-mediated diseaseGiovanni Monteleone, Francesco Pallone, Thomas T Macdonald
World Journal of Gastroenterology|May 27, 2009
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathiesMassimo-C Fantini, Francesco Pallone, Giovanni Monteleone
Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Interleukin-21 (IL-21) controls inflammatory pathways in the gutDaniele Fina, Roberta Caruso, Francesco Pallone, et al.
World Journal of Gastroenterology|September 25, 2012
Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?Stella Tammaro, Roberta Caruso, Francesco Pallone, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|February 3, 2007
Treatment with biologic therapies and the risk of cancer in patients with IBDLivia Biancone, Emma Calabrese, Carmelina Petruzziello, et al.
Current Opinion in Gastroenterology|June 9, 2006
New mediators of immunity and inflammation in inflammatory bowel diseaseGiovanni Monteleone, Daniele Fina, Roberta Caruso, et al.
Expert Review of Clinical Immunology|July 3, 2010
Role of IL-21 in inflammatory bowel diseaseFrancesco Pallone, Daniele Fina, Roberta Caruso, et al.
Expert Opinion on Therapeutic Targets|March 12, 2011
Targeting interleukin-21 in inflammatory diseasesMassimiliano Sarra, Eleonora Franzè, Francesco Pallone, et al.
Digestive Diseases (Basel, Switzerland)|September 15, 2015
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in ManIrene Marafini, Erika Angelucci, Francesco Pallone, et al.
Pageof 19